Time spent in hypoglycemia is comparable when the same amount of exercise is performed 5 or 2 days weekly: a randomized crossover study in people with type 1 diabetes

Isabelle Isa Kristin Steineck, Ajenthen G Ranjan, Signe Schmidt, Kirsten Norgaard, Isabelle Isa Kristin Steineck, Ajenthen G Ranjan, Signe Schmidt, Kirsten Norgaard

Abstract

Introduction: People with type 1 diabetes are recommended to exercise regularly. However, limited evidence exists on how frequency and duration of exercise affect the risk of hypoglycemia. The study aimed to compare the percentage of time spent in hypoglycemia between two 5-day periods with different frequency and duration of physical activity.

Research design and methods: In this outpatient randomized crossover study, 26 participants aged 18-65 years with type 1 diabetes for ≥2 years and insulin pump use for ≥1 year were included. After a 7-day observation period, participants completed two 5-day intervention periods separated by a washout period of at least 14 days. One period included five exercise sessions on 5 consecutive days (5S), each consisting of 4 min of resistance training and 30 min of aerobic exercise. Another period included two exercise sessions on 2 days with at least 2 days in between (2S), each consisting of 10 min of resistance training and 75 min of aerobic exercise. During each period, participants performed in total 150 min of aerobic exercise and 20 min of resistance training and wore continuous glucose monitors (Dexcom G6) and accelerometers (ActiGraph wGT3X-BT).

Results: Twenty insulin pump-treated adults (10 women) with type 1 diabetes completed the study. The baseline median (range) age was 48 (24-64) years, glycated hemoglobin 55 (44-66) mmol/mol, diabetes duration 24 (8-57) years, and body mass index 28.4 (22.3-35.8) kg/m2. No differences were observed between 5S and 2S in the percentage (mean±SD) of time spent below 3.9 mmol/L (3.5%±2.8% vs 4.5%±4.2%, p=0.28), time spent in 3.9-10.0 mmol/L (65.3%±15.0% vs 68.5%±13.6%, p=0.31), time spent above 10.0 mmol/L (31.2%±16.4% vs 27.3%±14.5%, p=0.15), mean glucose (8.7±1.3 mmol/L vs 8.5±1.2 mmol/L, p=0.33) and glycemic variability (35.8%±5.3% vs 35.8%±6.6%, p=0.97).

Conclusions: Time spent in hypoglycemia was comparable between the two 5-day periods with different duration and frequency of physical activity.

Trial registration number: NCT04089462.

Keywords: diabetes mellitus; exercise; hypoglycemia; type 1.

Conflict of interest statement

Competing interests: IIKS has received speaker grants from Roche Diabetes Care and Rubin Medical. SS has served on the continuous glucose monitoring advisory board of Roche Diabetes Care. KN serves as adviser for Medtronic, Abbott and Novo Nordisk A/S, owns shares in Novo Nordisk A/S, has received research grants from Novo Nordisk A/S, Zealand Pharma, Medtronic and Roche Diabetes Care, and has received fees for speaking from Medtronic, Roche Diabetes Care, Rubin Medical, Sanofi, Novo Nordisk A/S, Zealand Pharma and Dexcom. AGR declares no duality of interest associated with his contribution to this manuscript.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Continuous glucose monitoring data on the 20 participants who completed the study. Data are presented as mean±SD of the percentage of time below 3.0 mmol/L, time below 3.9 mmol/L, time in range 3.9–10 mmol/L, time above 10.0 mmol/L and time above 13.9 mmol/L.

References

    1. Pierre-Louis B, Guddati AK, Khyzar Hayat Syed M, et al. . Exercise capacity as an independent risk factor for adverse cardiovascular outcomes among nondiabetic and diabetic patients. Arch Med Sci 2014;10:25–32. 10.5114/aoms.2014.40731
    1. Wu N, Bredin SSD, Guan Y, et al. . Cardiovascular health benefits of exercise training in persons living with type 1 diabetes: a systematic review and meta-analysis. J Clin Med 2019;8:253. 10.3390/jcm8020253
    1. Codella R, Terruzzi I, Luzi L. Why should people with type 1 diabetes exercise regularly? Acta Diabetol 2017;54:615–30. 10.1007/s00592-017-0978-x
    1. American Diabetes Association 5. Lifestyle Management: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019;42:S46–60. 10.2337/dc19-S005
    1. Plotnikoff RC, Taylor LM, Wilson PM, et al. . Factors associated with physical activity in Canadian adults with diabetes. Med Sci Sports Exerc 2006;38:1526–34. 10.1249/01.mss.0000228937.86539.95
    1. McCarthy MM, Funk M, Grey M. Cardiovascular health in adults with type 1 diabetes. Prev Med 2016;91:138–43. 10.1016/j.ypmed.2016.08.019
    1. Reddy R, El Youssef J, Winters-Stone K, et al. . The effect of exercise on sleep in adults with type 1 diabetes. Diabetes Obes Metab 2018;20:443–7. 10.1111/dom.13065
    1. Brazeau A-S, Rabasa-Lhoret R, Strychar I, et al. . Barriers to physical activity among patients with type 1 diabetes. Diabetes Care 2008;31:2108–9. 10.2337/dc08-0720
    1. Riddell MC, Gallen IW, Smart CE, et al. . Exercise management in type 1 diabetes: a consensus statement. Lancet Diabetes Endocrinol 2017;5:377–90. 10.1016/S2213-8587(17)30014-1
    1. Yardley JE, Kenny GP, Perkins BA, et al. . Effects of performing resistance exercise before versus after aerobic exercise on glycemia in type 1 diabetes. Diabetes Care 2012;35:669–75. 10.2337/dc11-1844
    1. Campbell MD, Walker M, Bracken RM, et al. . Insulin therapy and dietary adjustments to normalize glycemia and prevent nocturnal hypoglycemia after evening exercise in type 1 diabetes: a randomized controlled trial. BMJ Open Diabetes Res Care 2015;3:e000085. 10.1136/bmjdrc-2015-000085
    1. Zaharieva DP, Riddell MC. Insulin management strategies for exercise in diabetes. Can J Diabetes 2017;41:507–16. 10.1016/j.jcjd.2017.07.004
    1. Zaharieva D, Yavelberg L, Jamnik V, et al. . The effects of basal insulin suspension at the start of exercise on blood glucose levels during continuous versus circuit-based exercise in individuals with type 1 diabetes on continuous subcutaneous insulin infusion. Diabetes Technol Ther 2017;19:370–8. 10.1089/dia.2017.0010
    1. Heise T, Zijlstra E, Nosek L, et al. . Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: a randomized, double-blind, crossover trial. Diabetes Obes Metab 2017;19:208–15. 10.1111/dom.12803
    1. Bohn B, Herbst A, Pfeifer M, et al. . Impact of physical activity on glycemic control and prevalence of cardiovascular risk factors in adults with type 1 diabetes: a cross-sectional multicenter study of 18,028 patients. Diabetes Care 2015;38:1536–43. 10.2337/dc15-0030
    1. Kennedy A, Nirantharakumar K, Chimen M, et al. . Does exercise improve glycaemic control in type 1 diabetes? A systematic review and meta-analysis. PLoS One 2013;8:e58861. 10.1371/journal.pone.0058861
    1. Hasan S, Shaw SM, Gelling LH, et al. . Exercise modes and their association with hypoglycemia episodes in adults with type 1 diabetes mellitus: a systematic review. BMJ Open Diabetes Res Care 2018;6:e000578. 10.1136/bmjdrc-2018-000578
    1. Cooper JG, Bakke Å, Dalen I, et al. . Factors associated with glycaemic control in adults with type 1 diabetes: a registry-based analysis including 7601 individuals from 34 centres in Norway. Diabet Med 2020;37:828–37. 10.1111/dme.14123
    1. Rhudy MB, Dreisbach SB, Moran MD, et al. . Cut points of the Actigraph GT9X for moderate and vigorous intensity physical activity at four different wear locations. J Sports Sci 2020;38:503–10. 10.1080/02640414.2019.1707956
    1. Toth L, Park S, Pittman W. Validity of activity Tracker step counts during walking, running, and activities of daily living. Translational Journal of the ACSM 2018;3:52–9.
    1. Lee PH, Suen LKP. The convergent validity of Actiwatch 2 and ActiGraph link accelerometers in measuring total sleeping period, wake after sleep onset, and sleep efficiency in free-living condition. Sleep Breath 2017;21:209–15. 10.1007/s11325-016-1406-0
    1. Høi-Hansen T, Pedersen-Bjergaard U, Thorsteinsson B. Classification of hypoglycemia awareness in people with type 1 diabetes in clinical practice. J Diabetes Complications 2010;24:392–7. 10.1016/j.jdiacomp.2009.07.006
    1. Murphy MH, Blair SN, Murtagh EM. Accumulated versus continuous exercise for health benefit: a review of empirical studies. Sports Med 2009;39:29–43. 10.2165/00007256-200939010-00003
    1. Shambrook P, Kingsley M, Taylor N, et al. . Accumulated or continuous exercise for glycaemic regulation and control: a systematic review with meta-analysis. BMJ Open Sport Exerc Med 2018;4:e000470. 10.1136/bmjsem-2018-000470
    1. Charlton J, Kilbride L, MacLean R, et al. . Delayed hypoglycaemia in people with type 1 diabetes after performing moderate intensity exercise before the evening meal. Practical Diabetes 2015;32:99–102. 10.1002/pdi.1933
    1. Scott S, Kempf P, Bally L, et al. . Carbohydrate intake in the context of exercise in people with type 1 diabetes. Nutrients 2019;11:3017. 10.3390/nu11123017
    1. Chomistek AK, Yuan C, Matthews CE, et al. . Physical activity assessment with the ActiGraph GT3X and doubly labeled water. Med Sci Sports Exerc 2017;49:1935–44. 10.1249/MSS.0000000000001299

Source: PubMed

3
订阅